Hematology/Oncology News

Disparities in hematopoietic stem cell transplantation utilization for blood cancers have narrowed over time but still persist, according to study results.

PHILADELPHIA — An AI model achieved high accuracy in detecting and distinguishing between cystic and solid pancreatic focal lesions during endoscopic ultrasound procedures, according to data presented at the ACG Annual Scientific Meeting.

Women who breastfeed after undergoing treatment for breast cancer are not at elevated risk for recurrence or new breast cancers, two studies presented at ESMO Congress showed.

Immunotherapy utilization for treatment of advanced kidney or bladder cancers varied by patients’ race or socioeconomic status, according to study results.

Individuals with cancer expressed a preference for early and frequent provider-initiated discussions about financial toxicity, according to study findings.

Decreasing the amount of dexamethasone that individuals with newly diagnosed multiple myeloma received did not affect survival, according to a secondary analysis of completed clinical trials.

Laura J. van ’t Veer, PhD, will receive the William L. McGuire Memorial Lecture Award at this year’s San Antonio Breast Cancer Symposium, scheduled for Dec. 10-13.

ORLANDO — Patients with localized high-risk cutaneous squamous cell carcinoma who received adjuvant radiation after clear margin surgery experienced decreased risk for local recurrence and nodal metastasis, according to study results.

I’m Luca Paruzzo, MD, a hematologist/oncologist working as a postdoctoral fellow at University of Pennsylvania under the mentorship of Marco Ruella, MD.

When Healio | Cell Therapy Next visited City of Hope in 2019, the institute boasted a robust cell therapy program, having treated 300 patients with the then-newly approved therapy.